These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27938708)

  • 21. Cancer immunotherapy in veterinary medicine: Current options and new developments.
    Regan D; Guth A; Coy J; Dow S
    Vet J; 2016 Jan; 207():20-28. PubMed ID: 26545847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies in cancer immunotherapy.
    Karyampudi L; Knutson KL
    Cancer Biomark; 2010; 6(5-6):291-305. PubMed ID: 20938089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The many challenges of veterinary oncology.
    Kidd C
    Can Vet J; 2008 Nov; 49(11):1132-5. PubMed ID: 19183739
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors.
    Di Fede G; Bronte G; Rizzo S; Rolfo Cervetto C; Cocorullo G; Gulotta G; Bazan V; Russo A
    Expert Opin Biol Ther; 2011 Nov; 11(11):1433-45. PubMed ID: 21663530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges in monoclonal antibody-based therapies.
    Samaranayake H; Wirth T; Schenkwein D; Räty JK; Ylä-Herttuala S
    Ann Med; 2009; 41(5):322-31. PubMed ID: 19234897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Historical development of monoclonal antibody therapeutics.
    Nissim A; Chernajovsky Y
    Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fundamentals of antibody-related therapy and diagnostics.
    Albrecht H; Radosevich JA; Babich M
    Drugs Today (Barc); 2009 Mar; 45(3):199-211. PubMed ID: 19436842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New monoclonal antibodies in renal transplantation.
    Vincenti F
    Minerva Urol Nefrol; 2003 Mar; 55(1):57-66. PubMed ID: 12773967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-targeted immunotherapy for treatment of malignancy.
    White CA; Weaver RL; Grillo-López AJ
    Annu Rev Med; 2001; 52():125-45. PubMed ID: 11160771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging trends and therapeutic applications of monoclonal antibodies.
    Mekala JR; Nalluri HP; Reddy PN; S B S; N S SK; G V S D SK; Dhiman R; Chamarthy S; Komaragiri RR; Manyam RR; Dirisala VR
    Gene; 2024 Oct; 925():148607. PubMed ID: 38797505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
    Siberil S; Dutertre CA; Boix C; Teillaud JL
    Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities.
    Wong ET
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7151s-7157s. PubMed ID: 16203815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibody and immunotherapy in oncology. Which patients benefit?].
    Schlimok G
    MMW Fortschr Med; 2001 Jun; 143(25):24-8. PubMed ID: 11468992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody conjugate therapeutics: challenges and potential.
    Teicher BA; Chari RV
    Clin Cancer Res; 2011 Oct; 17(20):6389-97. PubMed ID: 22003066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody engineering: facing new challenges in cancer therapy.
    Sanz L; Cuesta AM; Compte M; Alvarez-Vallina L
    Acta Pharmacol Sin; 2005 Jun; 26(6):641-8. PubMed ID: 15916728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of tumor immunity by therapeutic monoclonal antibodies.
    Abès R; Teillaud JL
    Cancer Metastasis Rev; 2011 Mar; 30(1):111-24. PubMed ID: 21267767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and experimental antibody-based therapeutics: insights, breakthroughs, setbacks and future directions.
    Murad JP; Lin OA; Espinosa EV; Khasawneh FT
    Curr Mol Med; 2013 Jan; 13(1):165-78. PubMed ID: 22834842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious disease.
    Corti D; Kearns JD
    Curr Opin Immunol; 2016 Jun; 40():51-61. PubMed ID: 26995095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomedicine in veterinary oncology.
    Lin TY; Rodriguez CO; Li Y
    Vet J; 2015 Aug; 205(2):189-97. PubMed ID: 25862394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.